Dedrogyl


Indications and Reactions:

Role Indications Reactions
Secondary
Asthma 24.4%
Product Used For Unknown Indication 20.8%
Drug Use For Unknown Indication 20.4%
Hiv Infection 9.0%
Rheumatoid Arthritis 8.1%
Osteoporosis 5.9%
Hepatitis C 4.5%
Nephrotic Syndrome 2.7%
Chronic Lymphocytic Leukaemia 1.4%
Glomerulonephritis 0.9%
Gout 0.5%
Multiple Myeloma 0.5%
Muscle Strain 0.5%
Renal Transplant 0.5%
Ventricular Hypoplasia 18.2%
Memory Impairment 15.9%
Weight Decreased 11.4%
Squamous Cell Carcinoma 9.1%
Sarcoidosis 6.8%
Neoplasm Malignant 4.5%
Squamous Cell Carcinoma Of Lung 4.5%
Alanine Aminotransferase Increased 2.3%
Deep Vein Thrombosis 2.3%
Drug Ineffective 2.3%
Enterococcus Test Positive 2.3%
Hypercalcaemia 2.3%
Lung Neoplasm 2.3%
Lung Neoplasm Malignant 2.3%
Metrorrhagia 2.3%
Pancoast's Syndrome 2.3%
Pancreatic Necrosis 2.3%
Platelet Count Decreased 2.3%
Pulmonary Artery Atresia 2.3%
Pulmonary Tuberculosis 2.3%
Concomitant
Drug Use For Unknown Indication 47.1%
Product Used For Unknown Indication 12.5%
Osteoporosis 5.3%
Hepatitis C 4.3%
Urinary Tract Infection 4.1%
Depression 2.9%
Hypertension 2.9%
Prophylaxis 2.5%
Epilepsy 1.8%
Hyperparathyroidism Secondary 1.8%
Multiple Myeloma 1.8%
Parkinson's Disease 1.6%
Premedication 1.6%
Transplant 1.6%
Tuberculosis 1.6%
Vitamin D Deficiency 1.4%
Chronic Lymphocytic Leukaemia 1.2%
Hiv Infection 1.2%
Nervousness 1.2%
Osteitis 1.2%
Vomiting 11.4%
Renal Failure Acute 8.6%
Pyrexia 7.1%
Status Epilepticus 7.1%
Thrombocytopenia 5.7%
General Physical Health Deterioration 4.3%
Ischaemia 4.3%
Neutropenia 4.3%
Peritoneal Cloudy Effluent 4.3%
Rhabdomyolysis 4.3%
Skin Lesion 4.3%
Small Intestinal Haemorrhage 4.3%
Somnolence 4.3%
Syncope 4.3%
Vascular Purpura 4.3%
Vision Blurred 4.3%
Weight Decreased 4.3%
Agranulocytosis 2.9%
Asthenia 2.9%
Chest Pain 2.9%

Drug Data